| Gene symbol | PSCA | Synonyms | PRO232, lncPSCA | Type of gene | protein-coding |
| Chromosome | 8 | Map location | 8q24.3 | dbXrefs | |
| Description | prostate stem cell antigen | ||||
| GTO ID | GTC1609 |
| Trial ID | NCT02744287 |
| Disease | Prostate Cancer | Castration-Resistant Prostate Carcinoma |
| Altered gene | PSCA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | BPX-601 |
| Phase | Phase1|Phase2 |
| Recruitment status | Suspended |
| Title | Safety and Activity Study of PSCA-Targeted CAR-T Cells (BPX-601) in Subjects With Selected Advanced Solid Tumors |
| Year | 2016 |
| Country | United States |
| Company sponsor | Bellicum Pharmaceuticals |
| Other ID(s) | BP-012 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||
|
|||||||||